New 'Tri-Antibody' takes on tough lymphoma
NCT ID NCT07308132
First seen Jan 05, 2026 · Last updated May 16, 2026 · Updated 23 times
Summary
This early-phase study is testing a new experimental drug called JNJ-95566692, a trispecific antibody designed to attach to three different targets on lymphoma cells and immune cells to help the body fight the cancer. The study includes about 130 adults with B-cell non-Hodgkin lymphoma whose cancer has come back or not responded to at least two prior treatments. The main goals are to find the safest dose and to check for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA NON-HODGKIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ankara Universitesi Hastaneleri Tibbi Farmakoloji Anabilim Dali Faz 1 Klinik Arastirma Merkezi
RECRUITINGAnkara, 06620, Turkey (Türkiye)
-
Centre Hospitalier Universitaire de Liege Domaine Universitaire du Sart Tilman
RECRUITINGLiège, 4000, Belgium
-
Koc Universitesi Hastanesi Faz 1 Klinik Arastirma Merkezi
RECRUITINGIstanbul, 34010, Turkey (Türkiye)
-
Macquarie University Hospital
RECRUITINGNorth Ryde, 2109, Australia
-
Peter MacCallum Cancer Centre
RECRUITINGMelbourne, 3000, Australia
-
SBU Ankara Dr. Abdurrahman Yurtaslan Onkoloji Egitim ve Arastirma Hastanesi Faz 1 Merkezi
RECRUITINGAnkara, 06200, Turkey (Türkiye)
-
Scientia Clinical Research
RECRUITINGRandwick, 2031, Australia
-
UZ Antwerpen
RECRUITINGEdegem, 2650, Belgium
Conditions
Explore the condition pages connected to this study.